Health Care Ticks Up With Shutdown in Focus -- Health Care Roundup

FeaturesDow Jones Newswires

Shares of health-care companies ticked up as traders hedged their bets ahead of a deadline on federal government funding.

Johnson & Johnson shares lagged the market after a U.S. Patent Office ruling opened the door to generic versions of J&J's cancer drug Zytiga, which generated $826 million in U.S. sales during the first nine months of 2017.

Continue Reading Below

-- Rob Curran, rob.curran@dowjones.com

(END) Dow Jones Newswires

January 19, 2018 16:19 ET (21:19 GMT)

Continue Reading Below